Next Article in Journal
The Tumor Suppressor p53 in Mucosal Melanoma of the Head and Neck
Next Article in Special Issue
Using Human iPSC-Derived Neurons to Uncover Activity-Dependent Non-Coding RNAs
Previous Article in Journal
Functional Characterization of the Versatile MYB Gene Family Uncovered Their Important Roles in Plant Development and Responses to Drought and Waterlogging in Sesame
Previous Article in Special Issue
Current Research on Non-Coding Ribonucleic Acid (RNA)
Article

Differential Expression of Serum MicroRNAs Supports CD4+ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma

1
Department of Clinical Veterinary Medicine, Swiss Institute of Equine Medicine, Vetsuisse Faculty, University of Bern and Agroscope, Länggassstrasse 124, 3012 Bern, Switzerland
2
Department of Clinical Research and Veterinary Public Health, Institute of Genetics, Vetsuisse Faculty, University of Bern, Bremgartenstrasse 109A, 3012 Bern, Switzerland
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Genes 2017, 8(12), 383; https://doi.org/10.3390/genes8120383
Received: 11 October 2017 / Revised: 21 November 2017 / Accepted: 1 December 2017 / Published: 12 December 2017
(This article belongs to the Special Issue Non-coding RNAs)
MicroRNAs (miRNAs) regulate post-transcriptional gene expression and may be exported from cells via exosomes or in partnership with RNA-binding proteins. MiRNAs in body fluids can act in a hormone-like manner and play important roles in disease initiation and progression. Hence, miRNAs are promising candidates as biomarkers. To identify serum miRNA biomarkers in the equine model of asthma we investigated small RNA derived from the serum of 34 control and 37 asthmatic horses. These samples were used for next generation sequencing, novel miRNA identification and differential miRNA expression analysis. We identified 11 significantly differentially expressed miRNAs between case and control horses: eca-miR-128, eca-miR-744, eca-miR-197, eca-miR-103, eca-miR-107a, eca-miR-30d, eca-miR-140-3p, eca-miR-7, eca-miR-361-3p, eca-miR-148b-3p and eca-miR-215. Pathway enrichment using experimentally validated target genes of the human homologous miRNAs showed a significant enrichment in the regulation of epithelial-to-mesenchymal transition (key player in airway remodeling in asthma) and the phosphatidylinositol (3,4,5)-triphosphate (PIP3) signaling pathway (modulator of CD4+ T cell maturation and function). Downregulated miR-128 and miR-744 supports a Th2/Th17 type immune response in severe equine asthma. View Full-Text
Keywords: miR-128; severe equine asthma; recurrent airway obstruction; microRNA; biomarker; RNA-sequencing; serum; hemolysis; differential expression miR-128; severe equine asthma; recurrent airway obstruction; microRNA; biomarker; RNA-sequencing; serum; hemolysis; differential expression
Show Figures

Graphical abstract

MDPI and ACS Style

Pacholewska, A.; Kraft, M.F.; Gerber, V.; Jagannathan, V. Differential Expression of Serum MicroRNAs Supports CD4+ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma. Genes 2017, 8, 383. https://doi.org/10.3390/genes8120383

AMA Style

Pacholewska A, Kraft MF, Gerber V, Jagannathan V. Differential Expression of Serum MicroRNAs Supports CD4+ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma. Genes. 2017; 8(12):383. https://doi.org/10.3390/genes8120383

Chicago/Turabian Style

Pacholewska, Alicja, Matthias F. Kraft, Vincent Gerber, and Vidhya Jagannathan. 2017. "Differential Expression of Serum MicroRNAs Supports CD4+ T Cell Differentiation into Th2/Th17 Cells in Severe Equine Asthma" Genes 8, no. 12: 383. https://doi.org/10.3390/genes8120383

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop